Comparing HR 18 → HR 50 — A RESOLUTION declaring the week of May 2 to 8, 2021, to be ...

Struck = only in HR 18 · added = only in HR 50.

Previous
Latest
House Resolution 18 - Introduced HOUSE RESOLUTION NO.
UNOFFICIAL COPY 21 RS BR 1818 A RESOLUTION declaring the week of May 2 to 8, 2021, to be Tardive Dyskinesia Awareness Week.
18 BY WOOD A Resolution designating Tardive Dyskinesia Awareness Week.
WHEREAS, many people with serious, chronic mental illness, such as schizophrenia, bipolar disorder, severe depression, and gastrointestinal disorders, including gastroparesis, nausea, and vomiting, require treatment with medications that work as dopamine receptor blocking agents (DRBAs), including antipsychotics;
WHEREAS, many people with serious, chronic mental illness, such as schizophrenia, bipolar disorder, and severe depression;
and WHEREAS, although ongoing treatment with these medications can be helpful and even lifesaving, for many people, it can also lead to Tardive Dyskinesia;
or gastrointestinal disorders, including gastroparesis, nausea, and vomiting;
and WHEREAS, Tardive Dyskinesia is a movement disorder that is characterized by random, involuntary, and uncontrolled movements of different muscles in the face, trunk, and extremities;
require treatment with medications that work as dopamine receptor blocking agents (DRBAs) such as antipsychotics;
and WHEREAS, Tardive Dyskinesia can develop months, years, or decades after a person starts taking DRBAs and even after discontinuing use of those medications.
and WHEREAS, ongoing treatment with DRBAs can be helpful or even life-saving, but for many people, the medications can lead to Tardive Dyskinesia (TD);
Not everyone who takes a DRBA develops Tardive Dyskinesia, but if it develops, it is often permanent;
and WHEREAS, TD is a movement disorder that is characterized by random, involuntary, and uncontrolled movements of different muscles in the face, torso, and extremities;
and WHEREAS, it is estimated that over 500,000 Americans suffer from Tardive Dyskinesia.
and WHEREAS, TD can significantly affect a person’s quality of life by making routine physical tasks more difficult;
According to the National Alliance for Mental Illness, one in every four patients receiving long-term treatment with an antipsychotic medication will experience Tardive Dyskinesia;
and WHEREAS, TD can be a permanent condition and may develop months, years, or even decades after a person starts taking DRBAs, even if the person discontinued using DRBAs;
and WHEREAS, years of difficult and challenging research have resulted in recent scientific breakthroughs, with two new treatments for Tardive Dyskinesia, approved by the United States Food and Drug Administration;
and WHEREAS, the National Institute of Neurological Disorders and Stroke estimates that at least 500,000 Americans suffer from TD;
and WHEREAS, Tardive Dyskinesia is often unrecognized and patients suffering from the illness are commonly misdiagnosed.
and WHEREAS, recent research has shown that between 20 and 30 percent of all people taking DRBAs will LSB 2566YH (1) 90 -1- dg/rn 1/2 H.R.
Regular screening for Tardive Dyskinesia in patients taking DRBA medications is recommended by the American Psychiatric Association;
18 experience TD, with women, African Americans, and the elderly being most at risk;
and WHEREAS, by declaring Tardive Dyskinesia Awareness Week, the House of Page 1 of 2 XXXX Jacketed UNOFFICIAL COPY 21 RS BR 1818 Representatives can raise awareness of Tardive Dyskinesia in the public and in the medical community;
and WHEREAS, years of difficult and challenging research have resulted in scientific breakthroughs leading to two new United States Food and Drug Administration-approved treatments for TD;
NOW, THEREFORE, Be it resolved by the House of Representatives of the General Assembly of the Commonwealth of Kentucky:
and WHEREAS, TD is often unrecognized or misdiagnosed as a mental illness, and as a result, patients are often prescribed more neurologic drugs which increase the probably the patient will develop a severe or disabling case of TD;
Section 1.
and WHEREAS, the American Psychiatric Association recommends regular TD screenings for patients taking DRBAs;
The House of Representatives does hereby designate the week of May 2 to 8, 2021, to be Tardive Dyskinesia Awareness Week.
and WHEREAS, the House of Representatives has the privilege of being in a position to raise public and medical community awareness of TD;
Section 2.
NOW THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES, That the House of Representatives designates the week of May 1, 2023, as Tardive Dyskinesia Awareness Week, and encourages every Iowan to become better informed about Tardive Dyskinesia.
The House of Representatives encourages each individual in the United States to be better informed and aware of Tardive Dyskinesia.
LSB 2566YH (1) 90 -2- dg/rn 2/2
Page 2 of 2 XXXX Jacketed